Service d'Hépato-Gastroentérologie B, Hôpital Saint Eloi, CHU Montpellier, France.
Vaccine. 2010 Sep 7;28(39):6411-6. doi: 10.1016/j.vaccine.2010.07.058. Epub 2010 Aug 1.
Up to 20% of health care workers are considered as non-responders to hepatitis B vaccination (anti-HBs<10 m UI/ml in serum). We have explored memory B cells differentiated in vitro into anti-HBs antibody-secreting cells (anti-HBs-SCs) by ELISPOT assay. Anti-HBs-SCs were detected in vaccinated responders (n = 11) and non-responders (n = 10) but IgG anti-HBs-SCs were significantly lower in the non-responder group (p<0.001). Low amounts of HBs antibodies were also quantified by ELISA in non-responders' sera. These results indicate that a suboptimal B cell response exists in non-responders to HBV vaccination. This B cell response may mediate a protection against clinically significant breakthrough hepatitis B infection.
高达 20%的医护人员被认为对乙肝疫苗接种无反应(血清中抗-HBs<10 mUI/ml)。我们通过 ELISPOT 检测法探索了在体外分化为产生抗-HBs 抗体的记忆 B 细胞(抗-HBs-SC)。在接种疫苗的应答者(n=11)和无应答者(n=10)中均检测到抗-HBs-SC,但无应答者组的 IgG 抗-HBs-SC 显著降低(p<0.001)。通过 ELISA 还定量检测了无应答者血清中的 HBs 抗体量。这些结果表明,HBV 疫苗接种无反应者存在亚最佳的 B 细胞反应。这种 B 细胞反应可能介导对临床显著突破性乙型肝炎感染的保护。